Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT04499963
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG:
Theracurmin HP
Sponsor
Richard Bedlack, M.D., Ph.D.